Alpha 2.0
Login Register
» Articles » PMID: 31918384

Early Initiation of High-dose Oral Ambroxol in Combination with Enzyme Replacement Therapy in a Neuropathic Gaucher Infant

Overview
Journal Blood Cells Mol Dis
Specialty Hematology
Date 2020 Jan 10
PMID 31918384
Citations 7
Authors
Shao-Yin Chu
Chun-Ching Chien
Wuh-Liang Hwu
Pen-Jung Wang
Yin-Hsiu Chien
Affiliations
Soon will be listed here.
Citing Articles

Rapid and long-lasting efficacy of high-dose ambroxol therapy for neuronopathic Gaucher disease: A case report and literature review.

Higashi K, Sonoda Y, Kaku N, Fujii F, Yamashita F, Lee S Mol Genet Genomic Med. 2024; 12(4):e2427.

PMID: 38553911 PMC: 10980885. DOI: 10.1002/mgg3.2427.

Exploring the efficacy and safety of Ambroxol in Gaucher disease: an overview of clinical studies.

Mohamed F, Al-Jasmi F Front Pharmacol. 2024; 15:1335058.

PMID: 38414738 PMC: 10896849. DOI: 10.3389/fphar.2024.1335058.

The use of Ambroxol for the treatment of Gaucher disease: A systematic review.

Abelleyra Lastoria D, Grewal S, Hughes D EJHaem. 2024; 5(1):206-221.

PMID: 38406552 PMC: 10887350. DOI: 10.1002/jha2.852.

Changing clinical manifestations of Gaucher disease in Taiwan.

Lu W, Chien Y, Tsai F, Hwu W, Chou Y, Chu S Orphanet J Rare Dis. 2023; 18(1):293.

PMID: 37715271 PMC: 10502973. DOI: 10.1186/s13023-023-02895-z.

Gaucher disease - more than just a rare lipid storage disease.

Roh J, Subramanian S, Weinreb N, Kartha R J Mol Med (Berl). 2022; 100(4):499-518.

PMID: 35066608 DOI: 10.1007/s00109-021-02174-z.